Centene Corp (CNC) Stock Analysis

Verdict: BUY

Medicaid rate repricing and ACA margin recovery drive rapid EPS normalization, offset by ongoing Medicaid membership attrition.

Investment score: 68/100

Analysis as of

Is Centene Corp stock worth reviewing? AI model thesis

Centene's core Medicaid and Marketplace businesses are undergoing a profitable turnaround as rate adjustments realign with post-redetermination member acuity, driving strong free cash flow and a forward P/E discount to peers.

7-factor investment score

Centene Corp opportunities and risks

What speaks for CNC

What speaks against CNC

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
CNCn/a0.2xn/a16.1%-2.6%27.9%
UNH24.3x0.8x15.0x22.5%3.1%6.9%
ELV18.2x0.4x13.7x39.0%2.5%7.1%
HUM35.5x0.3x17.2x13.7%0.9%-1.0%
MOH1236.2x0.2x25.0x34.6%-0.0%2.6%
HQY33.8x5.8x18.4x75.2%17.4%6.0%
Peer median33.8x0.4x17.2x34.6%2.5%6.0%

Frequently asked questions about Centene Corp (CNC)

Is CNC stock a good investment?

The cached TradeMates AI model rates Centene Corp as BUY with an investment score of 68/100. Centene's core Medicaid and Marketplace businesses are undergoing a profitable turnaround as rate adjustments realign with post-redetermination member acuity, driving strong free cash flow and a forward P/E discount to peers. This is algorithmic model output, not personal investment advice.

Is CNC stock a buy?

The TradeMates model verdict for CNC is BUY with an investment score of 68/100. Treat this as a model signal to review, not a personal buy recommendation.